PATENT CLAIM ANALYSIS

Application Number: 16279623
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["530", "300000"]

Abstract:
The present disclosure is generally directed to profiling peptides, compositions, and kits, as well as methods of use thereof. The profiling peptides comprise an Mcl-1 binding domain, and optionally a cellular uptake moiety. The methods of using such profiling peptides include predicting sensitivity of a cancer, selecting a treatment, treating a cancer, producing a sensitivity profile, and the like.

Claim (Index 124):
The method of  claim 122  wherein administering alvocidib to the subject with the MDP determined to be at least 25%.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 99.0
- Lexical Diversity: 1.62791
- Patent Class: 530.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16023360', '15847697', '15134051', '16132270', '11695321']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6074428102555186
- 35 USC 102 Novelty (BERT): 0.5471604362572465
- Combined Prediction Score: 0.6014145728556914
- Mean Citation Score: 275.88641399999995
- Max Citation Score: 428.94315
- Similarity Product: 198.3311253214001

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test